Authors:
Lewis, JB
Berl, T
Bain, RP
Rohde, RD
Lewis, EJ
Citation: Jb. Lewis et al., Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy, AM J KIDNEY, 34(5), 1999, pp. 809-817
Authors:
Wilmer, WA
Hebert, LA
Lewis, EJ
Rohde, RD
Whittier, F
Cattran, D
Levey, AS
Lewis, JB
Spitalewitz, S
Blumenthal, S
Bain, RP
Citation: Wa. Wilmer et al., Remission of nephrotic syndrome in type 1 diabetes: Long-term follow-up ofpatients in the captopril study, AM J KIDNEY, 34(2), 1999, pp. 308-314
Authors:
Freedman, BI
Wuerth, JP
Cartwright, K
Bain, RP
Dippe, S
Hershon, K
Mooradian, AD
Spinowitz, BS
Citation: Bi. Freedman et al., Design and baseline characteristics for the aminoguanidine clinical trial in overt type 2 diabetic nephropathy (ACTION II), CONTR CL TR, 20(5), 1999, pp. 493-510
Citation: Sz. Yanovski et al., Report of a National Institutes of Health-Centers for Disease Control and Prevention workshop on the feasibility of conducting a randomized clinical trial to estimate the long-term health effects of intentional weight loss in obese persons, AM J CLIN N, 69(3), 1999, pp. 366-372